Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
28201
28202
28203
28204
28205
28206
28207
28208
28209
28210
28211
28212
28213
28214
28215
28216
28217
28218
28219
28220
28221
28222
28223
28224
28225
28226
28227
28228
28229
28230
28231
28232
28233
28234
28235
28236
28237
28238
28239
28240
28241
28242
28243
28244
28245
28246
28247
28248
28249
28250
28251
28252
28253
28254
28255
28256
28257
28258
28259
28260
28261
28262
28263
28264
28265
28266
28267
28268
28269
28270
28271
28272
28273
28274
28275
28276
28277
28278
28279
28280
28281
28282
28283
28284
28285
28286
28287
28288
28289
28290
28291
28292
28293
28294
28295
28296
28297
28298
28299
28300
28301
28302
28303
28304
28305
28306
28307
28308
28309
28310
28311
28312
28313
28314
28315
28316
28317
28318
28319
28320
28321
28322
28323
28324
28325
28326
28327
28328
28329
28330
28331
28332
28333
28334
28335
28336
28337
28338
28339
28340
28341
28342
28343
28344
28345
28346
28347
28348
28349
28350
28351
28352
28353
28354
28355
28356
28357
28358
28359
28360
28361
28362
28363
28364
28365
28366
28367
28368
28369
28370
28371
28372
28373
28374
28375
28376
28377
28378
28379
28380
28381
28382
28383
28384
28385
28386
28387
28388
28389
28390
28391
28392
28393
28394
28395
28396
28397
28398
28399
28400
| UnnamedSample_HQ_transcript/41318|m.12120 | UnnamedSample_HQ_transcript/41318 | Coverage 0.955 too low. | a1bf64e9c5edd7f37da2ef49bb72e9f2 | 467 | Pfam | PF00069 | Protein kinase domain | 151 | 414 | 1.8E-47 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/65018|m.17033 | UnnamedSample_HQ_transcript/65018 | Coverage 0.119 too low. | b79f47d4a7f4a4f1eec5434b44fa42f7 | 292 | Pfam | PF00069 | Protein kinase domain | 1 | 89 | 2.5E-16 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/51288|m.14305 | UnnamedSample_HQ_transcript/51288 | Coverage 0.959 too low. | e57784239b5b7bcdee228cd480d83b60 | 646 | Pfam | PF05997 | Nucleolar protein,Nop52 | 1 | 150 | 1.3E-27 | T | 22-09-2020 | IPR010301 | Nucleolar, Nop52 |
| UnnamedSample_HQ_transcript/87840|m.20912 | UnnamedSample_HQ_transcript/87840 | Coverage 0.986 too low. | 8a6fef766f211d8ca68ceaf1b73ea2b1 | 428 | Pfam | PF00780 | CNH domain | 23 | 286 | 1.3E-32 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/36083|m.10953 | UnnamedSample_HQ_transcript/36083 | Coverage 0.347 too low. | e98f8c287f194337938c98f86102494a | 310 | Pfam | PF00595 | PDZ domain | 76 | 153 | 7.9E-17 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/36083|m.10953 | UnnamedSample_HQ_transcript/36083 | Coverage 0.347 too low. | e98f8c287f194337938c98f86102494a | 310 | Pfam | PF00595 | PDZ domain | 177 | 252 | 1.3E-17 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/47031|m.13371 | UnnamedSample_HQ_transcript/47031 | Coverage 0.632 too low. | 9343e5ef1206f754c280d765eb19141a | 549 | Pfam | PF00135 | Carboxylesterase family | 18 | 533 | 4.5E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/45220|m.12959 | UnnamedSample_HQ_transcript/45220 | Coverage 0.634 too low. | 9343e5ef1206f754c280d765eb19141a | 549 | Pfam | PF00135 | Carboxylesterase family | 18 | 533 | 4.5E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/19610|m.6764 | UnnamedSample_HQ_transcript/19610 | Coverage 0.746 too low. | 9343e5ef1206f754c280d765eb19141a | 549 | Pfam | PF00135 | Carboxylesterase family | 18 | 533 | 4.5E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/42047|m.12272 | UnnamedSample_HQ_transcript/42047 | Coverage 0.651 too low. | 9343e5ef1206f754c280d765eb19141a | 549 | Pfam | PF00135 | Carboxylesterase family | 18 | 533 | 4.5E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/55332|m.15096 | UnnamedSample_HQ_transcript/55332 | Coverage 0.585 too low. | 9343e5ef1206f754c280d765eb19141a | 549 | Pfam | PF00135 | Carboxylesterase family | 18 | 533 | 4.5E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/35379|m.10796 | UnnamedSample_HQ_transcript/35379 | Coverage 0.671 too low. | 9343e5ef1206f754c280d765eb19141a | 549 | Pfam | PF00135 | Carboxylesterase family | 18 | 533 | 4.5E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/50424|m.14108 | UnnamedSample_HQ_transcript/50424 | Coverage 0.601 too low. | 9343e5ef1206f754c280d765eb19141a | 549 | Pfam | PF00135 | Carboxylesterase family | 18 | 533 | 4.5E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/21649|m.7327 | UnnamedSample_HQ_transcript/21649 | Coverage 0.737 too low. | 9343e5ef1206f754c280d765eb19141a | 549 | Pfam | PF00135 | Carboxylesterase family | 18 | 533 | 4.5E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/59849|m.16031 | UnnamedSample_HQ_transcript/59849 | Coverage 0.554 too low. | 9343e5ef1206f754c280d765eb19141a | 549 | Pfam | PF00135 | Carboxylesterase family | 18 | 533 | 4.5E-138 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/62145|m.16475 | UnnamedSample_HQ_transcript/62145 | Identity 0.939 too low. | ef8c8c45fb76254aea2014af56b923b1 | 561 | Pfam | PF00135 | Carboxylesterase family | 19 | 525 | 3.7E-139 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/49300|m.13871 | UnnamedSample_HQ_transcript/49300 | Identity 0.917 too low. | ef8c8c45fb76254aea2014af56b923b1 | 561 | Pfam | PF00135 | Carboxylesterase family | 19 | 525 | 3.7E-139 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/65205|m.17062 | UnnamedSample_HQ_transcript/65205 | Coverage 0.774 too low. | ef8c8c45fb76254aea2014af56b923b1 | 561 | Pfam | PF00135 | Carboxylesterase family | 19 | 525 | 3.7E-139 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/57574|m.15561 | UnnamedSample_HQ_transcript/57574 | Coverage 0.756 too low. | ef8c8c45fb76254aea2014af56b923b1 | 561 | Pfam | PF00135 | Carboxylesterase family | 19 | 525 | 3.7E-139 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/10422|m.3965 | UnnamedSample_HQ_transcript/10422 | Unmapped. | 9805cda60ac7e880da01646cbc6394b1 | 1337 | Pfam | PF00910 | RNA helicase | 1247 | 1337 | 1.7E-14 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/10422|m.3965 | UnnamedSample_HQ_transcript/10422 | Unmapped. | 9805cda60ac7e880da01646cbc6394b1 | 1337 | Pfam | PF08762 | CRPV capsid protein like | 623 | 833 | 6.8E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/79727|m.19662 | UnnamedSample_HQ_transcript/79727 | Coverage 0.935 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 296 | 362 | 6.7E-5 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/79727|m.19662 | UnnamedSample_HQ_transcript/79727 | Coverage 0.935 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 52 | 296 | 1.2E-15 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/84343|m.20390 | UnnamedSample_HQ_transcript/84343 | Coverage 0.934 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 296 | 362 | 6.7E-5 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/84343|m.20390 | UnnamedSample_HQ_transcript/84343 | Coverage 0.934 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 52 | 296 | 1.2E-15 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/72538|m.18387 | UnnamedSample_HQ_transcript/72538 | Coverage 0.819 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 296 | 362 | 6.7E-5 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/72538|m.18387 | UnnamedSample_HQ_transcript/72538 | Coverage 0.819 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 52 | 296 | 1.2E-15 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/77081|m.19214 | UnnamedSample_HQ_transcript/77081 | Identity 0.913 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 296 | 362 | 6.7E-5 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/77081|m.19214 | UnnamedSample_HQ_transcript/77081 | Identity 0.913 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 52 | 296 | 1.2E-15 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/79972|m.19709 | UnnamedSample_HQ_transcript/79972 | Coverage 0.936 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 296 | 362 | 6.7E-5 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/79972|m.19709 | UnnamedSample_HQ_transcript/79972 | Coverage 0.936 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 52 | 296 | 1.2E-15 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/81213|m.19919 | UnnamedSample_HQ_transcript/81213 | Identity 0.913 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 296 | 362 | 6.7E-5 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/81213|m.19919 | UnnamedSample_HQ_transcript/81213 | Identity 0.913 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 52 | 296 | 1.2E-15 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/74378|m.18718 | UnnamedSample_HQ_transcript/74378 | Coverage 0.814 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 296 | 362 | 6.7E-5 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/74378|m.18718 | UnnamedSample_HQ_transcript/74378 | Coverage 0.814 too low. | 19977538f86df199016252e5940e918e | 389 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 52 | 296 | 1.2E-15 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/17479|m.6150 | UnnamedSample_HQ_transcript/17479 | Coverage 0.976 too low. | 8348c425a915d1856512c4f9b22e0009 | 897 | Pfam | PF03165 | MH1 domain | 28 | 129 | 1.3E-19 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/4979|m.2188 | UnnamedSample_HQ_transcript/4979 | Coverage 0.955 too low. | 5890dc2b6eda0f63251d138e8c7e0b5b | 1115 | Pfam | PF00008 | EGF-like domain | 377 | 406 | 7.2E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/4979|m.2188 | UnnamedSample_HQ_transcript/4979 | Coverage 0.955 too low. | 5890dc2b6eda0f63251d138e8c7e0b5b | 1115 | Pfam | PF00008 | EGF-like domain | 799 | 822 | 1.2E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/4979|m.2188 | UnnamedSample_HQ_transcript/4979 | Coverage 0.955 too low. | 5890dc2b6eda0f63251d138e8c7e0b5b | 1115 | Pfam | PF02210 | Laminin G domain | 865 | 988 | 2.5E-14 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/4979|m.2188 | UnnamedSample_HQ_transcript/4979 | Coverage 0.955 too low. | 5890dc2b6eda0f63251d138e8c7e0b5b | 1115 | Pfam | PF02210 | Laminin G domain | 655 | 776 | 1.0E-18 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/4979|m.2188 | UnnamedSample_HQ_transcript/4979 | Coverage 0.955 too low. | 5890dc2b6eda0f63251d138e8c7e0b5b | 1115 | Pfam | PF02210 | Laminin G domain | 44 | 164 | 1.5E-24 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/4979|m.2188 | UnnamedSample_HQ_transcript/4979 | Coverage 0.955 too low. | 5890dc2b6eda0f63251d138e8c7e0b5b | 1115 | Pfam | PF02210 | Laminin G domain | 229 | 347 | 2.8E-16 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/25829|m.8430 | UnnamedSample_HQ_transcript/25829 | Coverage 0.835 too low. | 8fdb893672148dddb361c14111719bb4 | 687 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 355 | 405 | 7.7E-13 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/27944|m.8952 | UnnamedSample_HQ_transcript/27944 | Coverage 0.626 too low. | 4b05c5c50d13aa244ed8710f629e4d79 | 949 | Pfam | PF03154 | Atrophin-1 family | 870 | 944 | 1.2E-18 | T | 22-09-2020 | IPR002951 | Atrophin-like |
| UnnamedSample_HQ_transcript/7666|m.3075 | UnnamedSample_HQ_transcript/7666 | Coverage 0.193 too low. | fdf333c6191335ca398c50206d4d0fab | 1001 | Pfam | PF19057 | PH domain | 362 | 495 | 2.6E-38 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7666|m.3075 | UnnamedSample_HQ_transcript/7666 | Coverage 0.193 too low. | fdf333c6191335ca398c50206d4d0fab | 1001 | Pfam | PF19056 | WD40 repeated domain | 661 | 889 | 1.4E-60 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/7666|m.3075 | UnnamedSample_HQ_transcript/7666 | Coverage 0.193 too low. | fdf333c6191335ca398c50206d4d0fab | 1001 | Pfam | PF00621 | RhoGEF domain | 157 | 337 | 7.9E-36 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/6240|m.2619 | UnnamedSample_HQ_transcript/6240 | Identity 0.753 too low. | cb13a3a0ec7c05453edc97e1e3d68dd3 | 1363 | Pfam | PF00621 | RhoGEF domain | 971 | 1157 | 7.9E-37 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 545 | 625 | 5.6E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 900 | 984 | 9.1E-9 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 1368 | 1454 | 2.4E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 1085 | 1170 | 1.8E-6 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 1651 | 1737 | 1.8E-11 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 456 | 537 | 4.6E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 1745 | 1834 | 9.6E-17 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 1184 | 1265 | 3.3E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 362 | 446 | 6.1E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 995 | 1080 | 4.3E-9 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 719 | 804 | 4.0E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 1558 | 1643 | 6.3E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/1966|m.1043 | UnnamedSample_HQ_transcript/1966 | Coverage 0.048 too low. | b9ec1b797b87085bd5df9f85b9dfd08f | 1872 | Pfam | PF00630 | Filamin/ABP280 repeat | 192 | 266 | 4.7E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/10018|m.3837 | UnnamedSample_HQ_transcript/10018 | Identity 0.702 too low. | 33a9e4c9ef550868524d7f4a4ae0b012 | 1184 | Pfam | PF01753 | MYND finger | 1145 | 1182 | 5.7E-8 | T | 22-09-2020 | IPR002893 | Zinc finger, MYND-type |
| UnnamedSample_HQ_transcript/1666|m.923 | UnnamedSample_HQ_transcript/1666 | Unmapped. | bb38dc2e56df98836ccbe18dd1d2110a | 1843 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1477 | 1802 | 2.9E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/1666|m.923 | UnnamedSample_HQ_transcript/1666 | Unmapped. | bb38dc2e56df98836ccbe18dd1d2110a | 1843 | Pfam | PF00910 | RNA helicase | 415 | 523 | 6.9E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/18943|m.6563 | UnnamedSample_HQ_transcript/18943 | Coverage 0.049 too low. | 567149750e6a5ae1ce1bf93ae9747273 | 346 | Pfam | PF07679 | Immunoglobulin I-set domain | 247 | 320 | 2.0E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/18943|m.6563 | UnnamedSample_HQ_transcript/18943 | Coverage 0.049 too low. | 567149750e6a5ae1ce1bf93ae9747273 | 346 | Pfam | PF07679 | Immunoglobulin I-set domain | 129 | 213 | 3.7E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/18943|m.6563 | UnnamedSample_HQ_transcript/18943 | Coverage 0.049 too low. | 567149750e6a5ae1ce1bf93ae9747273 | 346 | Pfam | PF07679 | Immunoglobulin I-set domain | 20 | 108 | 7.7E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/70342|m.17987 | UnnamedSample_HQ_transcript/70342 | Coverage 0.877 too low. | 323f6e01bbf3dd8842f91d054e5655ac | 299 | Pfam | PF01248 | Ribosomal protein L7Ae/L30e/S12e/Gadd45 family | 97 | 158 | 8.8E-5 | T | 22-09-2020 | IPR004038 | Ribosomal protein L7Ae/L30e/S12e/Gadd45 |
| UnnamedSample_HQ_transcript/96667|m.22185 | UnnamedSample_HQ_transcript/96667 | Coverage 0.832 too low. | 323f6e01bbf3dd8842f91d054e5655ac | 299 | Pfam | PF01248 | Ribosomal protein L7Ae/L30e/S12e/Gadd45 family | 97 | 158 | 8.8E-5 | T | 22-09-2020 | IPR004038 | Ribosomal protein L7Ae/L30e/S12e/Gadd45 |
| UnnamedSample_HQ_transcript/91182|m.21430 | UnnamedSample_HQ_transcript/91182 | Coverage 0.859 too low. | 323f6e01bbf3dd8842f91d054e5655ac | 299 | Pfam | PF01248 | Ribosomal protein L7Ae/L30e/S12e/Gadd45 family | 97 | 158 | 8.8E-5 | T | 22-09-2020 | IPR004038 | Ribosomal protein L7Ae/L30e/S12e/Gadd45 |
| UnnamedSample_HQ_transcript/66055|m.17224 | UnnamedSample_HQ_transcript/66055 | Coverage 0.882 too low. | 323f6e01bbf3dd8842f91d054e5655ac | 299 | Pfam | PF01248 | Ribosomal protein L7Ae/L30e/S12e/Gadd45 family | 97 | 158 | 8.8E-5 | T | 22-09-2020 | IPR004038 | Ribosomal protein L7Ae/L30e/S12e/Gadd45 |
| UnnamedSample_HQ_transcript/11785|m.4422 | UnnamedSample_HQ_transcript/11785 | Coverage 0.920 too low. | 3954605c08e258fa628ecdbdde94f95b | 865 | Pfam | PF00053 | Laminin EGF domain | 231 | 276 | 1.9E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11785|m.4422 | UnnamedSample_HQ_transcript/11785 | Coverage 0.920 too low. | 3954605c08e258fa628ecdbdde94f95b | 865 | Pfam | PF00053 | Laminin EGF domain | 585 | 627 | 7.1E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11785|m.4422 | UnnamedSample_HQ_transcript/11785 | Coverage 0.920 too low. | 3954605c08e258fa628ecdbdde94f95b | 865 | Pfam | PF00053 | Laminin EGF domain | 375 | 431 | 1.4E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11785|m.4422 | UnnamedSample_HQ_transcript/11785 | Coverage 0.920 too low. | 3954605c08e258fa628ecdbdde94f95b | 865 | Pfam | PF00053 | Laminin EGF domain | 537 | 579 | 2.8E-11 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11785|m.4422 | UnnamedSample_HQ_transcript/11785 | Coverage 0.920 too low. | 3954605c08e258fa628ecdbdde94f95b | 865 | Pfam | PF00053 | Laminin EGF domain | 279 | 327 | 5.3E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11785|m.4422 | UnnamedSample_HQ_transcript/11785 | Coverage 0.920 too low. | 3954605c08e258fa628ecdbdde94f95b | 865 | Pfam | PF00053 | Laminin EGF domain | 486 | 534 | 1.8E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/11785|m.4422 | UnnamedSample_HQ_transcript/11785 | Coverage 0.920 too low. | 3954605c08e258fa628ecdbdde94f95b | 865 | Pfam | PF00053 | Laminin EGF domain | 434 | 483 | 4.0E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/745|m.516 | UnnamedSample_HQ_transcript/745 | Identity 0.768 too low. | ba148f4695e173bf38e480590c989cb8 | 2168 | Pfam | PF00569 | Zinc finger, ZZ type | 1510 | 1550 | 1.6E-13 | T | 22-09-2020 | IPR000433 | Zinc finger, ZZ-type |
| UnnamedSample_HQ_transcript/745|m.516 | UnnamedSample_HQ_transcript/745 | Identity 0.768 too low. | ba148f4695e173bf38e480590c989cb8 | 2168 | Pfam | PF00439 | Bromodomain | 894 | 976 | 6.7E-18 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/745|m.516 | UnnamedSample_HQ_transcript/745 | Identity 0.768 too low. | ba148f4695e173bf38e480590c989cb8 | 2168 | Pfam | PF02135 | TAZ zinc finger | 11 | 63 | 4.6E-13 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/745|m.516 | UnnamedSample_HQ_transcript/745 | Identity 0.768 too low. | ba148f4695e173bf38e480590c989cb8 | 2168 | Pfam | PF02135 | TAZ zinc finger | 1579 | 1650 | 6.4E-11 | T | 22-09-2020 | IPR000197 | Zinc finger, TAZ-type |
| UnnamedSample_HQ_transcript/745|m.516 | UnnamedSample_HQ_transcript/745 | Identity 0.768 too low. | ba148f4695e173bf38e480590c989cb8 | 2168 | Pfam | PF08214 | Histone acetylation protein | 1138 | 1456 | 1.9E-74 | T | 22-09-2020 | IPR013178 | Histone acetyltransferase Rtt109/CBP |
| UnnamedSample_HQ_transcript/745|m.516 | UnnamedSample_HQ_transcript/745 | Identity 0.768 too low. | ba148f4695e173bf38e480590c989cb8 | 2168 | Pfam | PF06001 | Domain of Unknown Function (DUF902) | 988 | 1027 | 4.8E-23 | T | 22-09-2020 | IPR010303 | CREB-binding protein/p300, atypical RING domain |
| UnnamedSample_HQ_transcript/745|m.516 | UnnamedSample_HQ_transcript/745 | Identity 0.768 too low. | ba148f4695e173bf38e480590c989cb8 | 2168 | Pfam | PF02172 | KIX domain | 407 | 452 | 3.0E-13 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/745|m.516 | UnnamedSample_HQ_transcript/745 | Identity 0.768 too low. | ba148f4695e173bf38e480590c989cb8 | 2168 | Pfam | PF02172 | KIX domain | 342 | 371 | 1.5E-5 | T | 22-09-2020 | IPR003101 | Coactivator CBP, KIX domain |
| UnnamedSample_HQ_transcript/745|m.516 | UnnamedSample_HQ_transcript/745 | Identity 0.768 too low. | ba148f4695e173bf38e480590c989cb8 | 2168 | Pfam | PF09030 | Creb binding | 1887 | 1970 | 4.7E-16 | T | 22-09-2020 | IPR014744 | Nuclear receptor coactivator, CREB-bp-like, interlocking |
| UnnamedSample_HQ_transcript/25423|m.8323 | UnnamedSample_HQ_transcript/25423 | Identity 0.765 too low. | 484afc8182554a5dc049153140d2358d | 469 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 146 | 403 | 3.0E-115 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/32374|m.10045 | UnnamedSample_HQ_transcript/32374 | Identity 0.778 too low. | 484afc8182554a5dc049153140d2358d | 469 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 146 | 403 | 3.0E-115 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/15180|m.5456 | UnnamedSample_HQ_transcript/15180 | Identity 0.801 too low. | 484afc8182554a5dc049153140d2358d | 469 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 146 | 403 | 3.0E-115 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/11686|m.4386 | UnnamedSample_HQ_transcript/11686 | Identity 0.916 too low. | 484afc8182554a5dc049153140d2358d | 469 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 146 | 403 | 3.0E-115 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/16998|m.6008 | UnnamedSample_HQ_transcript/16998 | Identity 0.792 too low. | 484afc8182554a5dc049153140d2358d | 469 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 146 | 403 | 3.0E-115 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/3248|m.1541 | UnnamedSample_HQ_transcript/3248 | Coverage 0.062 too low. | 67ef22344c74b56fd6d4989f2bc0f430 | 1573 | Pfam | PF00501 | AMP-binding enzyme | 975 | 1412 | 1.2E-57 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/3248|m.1541 | UnnamedSample_HQ_transcript/3248 | Coverage 0.062 too low. | 67ef22344c74b56fd6d4989f2bc0f430 | 1573 | Pfam | PF00501 | AMP-binding enzyme | 347 | 796 | 4.3E-32 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/3248|m.1541 | UnnamedSample_HQ_transcript/3248 | Coverage 0.062 too low. | 67ef22344c74b56fd6d4989f2bc0f430 | 1573 | Pfam | PF06464 | DMAP1-binding Domain | 9 | 70 | 5.3E-16 | T | 22-09-2020 | IPR010506 | DMAP1-binding domain |
| UnnamedSample_HQ_transcript/98068|m.22376 | UnnamedSample_HQ_transcript/98068 | Coverage 0.927 too low. | e1b80ebb9d680e76c151b26ff192cc68 | 278 | Pfam | PF17780 | OCRE domain | 2 | 26 | 2.5E-5 | T | 22-09-2020 | IPR041591 | OCRE domain |
| UnnamedSample_HQ_transcript/98068|m.22376 | UnnamedSample_HQ_transcript/98068 | Coverage 0.927 too low. | e1b80ebb9d680e76c151b26ff192cc68 | 278 | Pfam | PF00498 | FHA domain | 156 | 232 | 3.8E-13 | T | 22-09-2020 | IPR000253 | Forkhead-associated (FHA) domain |
| UnnamedSample_HQ_transcript/99|m.98 | UnnamedSample_HQ_transcript/99 | Coverage 0.134 too low. | cf91b33526136ba6fd451d321ede25cc | 850 | Pfam | PF01030 | Receptor L domain | 472 | 585 | 2.2E-25 | T | 22-09-2020 | IPR000494 | Receptor L-domain |
| UnnamedSample_HQ_transcript/99|m.98 | UnnamedSample_HQ_transcript/99 | Coverage 0.134 too low. | cf91b33526136ba6fd451d321ede25cc | 850 | Pfam | PF01030 | Receptor L domain | 166 | 277 | 1.2E-26 | T | 22-09-2020 | IPR000494 | Receptor L-domain |
| UnnamedSample_HQ_transcript/99|m.98 | UnnamedSample_HQ_transcript/99 | Coverage 0.134 too low. | cf91b33526136ba6fd451d321ede25cc | 850 | Pfam | PF00757 | Furin-like cysteine rich region | 307 | 456 | 1.5E-25 | T | 22-09-2020 | IPR006211 | Furin-like cysteine-rich domain |
| UnnamedSample_HQ_transcript/51309|m.14310 | UnnamedSample_HQ_transcript/51309 | Coverage 0.854 too low. | a319a03e6126fc0f334fca54da8c5813 | 551 | Pfam | PF07993 | Male sterility protein | 64 | 333 | 3.1E-71 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/51309|m.14310 | UnnamedSample_HQ_transcript/51309 | Coverage 0.854 too low. | a319a03e6126fc0f334fca54da8c5813 | 551 | Pfam | PF03015 | Male sterility protein | 415 | 506 | 5.5E-27 | T | 22-09-2020 | IPR033640 | Fatty acyl-CoA reductase, C-terminal |
| UnnamedSample_HQ_transcript/25934|m.8460 | UnnamedSample_HQ_transcript/25934 | Identity 0.664 too low. | ab6a38743278e5bae72608b791244c7e | 497 | Pfam | PF00501 | AMP-binding enzyme | 75 | 490 | 1.0E-58 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/10158|m.3879 | UnnamedSample_HQ_transcript/10158 | Coverage 0.985 too low. | 3c93b84dae002d9318d2aeee95031e00 | 275 | Pfam | PF07690 | Major Facilitator Superfamily | 17 | 169 | 8.2E-9 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/65976|m.17203 | UnnamedSample_HQ_transcript/65976 | Coverage 0.901 too low. | c71c612c937322b3d12c10fcee9fa077 | 501 | Pfam | PF02171 | Piwi domain | 156 | 461 | 3.7E-86 | T | 22-09-2020 | IPR003165 | Piwi domain |
| UnnamedSample_HQ_transcript/53003|m.14645 | UnnamedSample_HQ_transcript/53003 | Coverage 0.972 too low. | 4d5a7596dea192f9ee3343d07eac8718 | 644 | Pfam | PF00621 | RhoGEF domain | 384 | 562 | 3.4E-44 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/53003|m.14645 | UnnamedSample_HQ_transcript/53003 | Coverage 0.972 too low. | 4d5a7596dea192f9ee3343d07eac8718 | 644 | Pfam | PF00018 | SH3 domain | 301 | 345 | 1.1E-10 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/9672|m.3721 | UnnamedSample_HQ_transcript/9672 | Unmapped. | c4c36a6e84579dbb1d96ca76605dbced | 1185 | Pfam | PF08762 | CRPV capsid protein like | 887 | 1097 | 5.7E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/108162|m.23603 | UnnamedSample_HQ_transcript/108162 | Coverage 0.755 too low. | debe760730917489de6d928c719c9774 | 224 | Pfam | PF05199 | GMC oxidoreductase | 66 | 210 | 1.9E-39 | T | 22-09-2020 | IPR007867 | Glucose-methanol-choline oxidoreductase, C-terminal |
| UnnamedSample_HQ_transcript/8928|m.3489 | UnnamedSample_HQ_transcript/8928 | Coverage 0.795 too low. | d2146e0c198aedce93e7f914d5ceb7f6 | 636 | Pfam | PF13246 | Cation transport ATPase (P-type) | 514 | 597 | 2.5E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8928|m.3489 | UnnamedSample_HQ_transcript/8928 | Coverage 0.795 too low. | d2146e0c198aedce93e7f914d5ceb7f6 | 636 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 37 | 104 | 3.7E-17 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/8928|m.3489 | UnnamedSample_HQ_transcript/8928 | Coverage 0.795 too low. | d2146e0c198aedce93e7f914d5ceb7f6 | 636 | Pfam | PF00122 | E1-E2 ATPase | 338 | 434 | 4.4E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8928|m.3489 | UnnamedSample_HQ_transcript/8928 | Coverage 0.795 too low. | d2146e0c198aedce93e7f914d5ceb7f6 | 636 | Pfam | PF00122 | E1-E2 ATPase | 169 | 272 | 6.5E-24 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/2040|m.1073 | UnnamedSample_HQ_transcript/2040 | Unmapped. | 81d8ff3ef09c7ed90fe5ae5b031c9180 | 1262 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 491 | 859 | 1.8E-9 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/47884|m.13554 | UnnamedSample_HQ_transcript/47884 | Coverage 0.519 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF00107 | Zinc-binding dehydrogenase | 188 | 317 | 1.3E-13 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/47884|m.13554 | UnnamedSample_HQ_transcript/47884 | Coverage 0.519 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF08240 | Alcohol dehydrogenase GroES-like domain | 65 | 126 | 1.8E-13 | T | 22-09-2020 | IPR013154 | Alcohol dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/28011|m.8972 | UnnamedSample_HQ_transcript/28011 | Coverage 0.434 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF00107 | Zinc-binding dehydrogenase | 188 | 317 | 1.3E-13 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/28011|m.8972 | UnnamedSample_HQ_transcript/28011 | Coverage 0.434 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF08240 | Alcohol dehydrogenase GroES-like domain | 65 | 126 | 1.8E-13 | T | 22-09-2020 | IPR013154 | Alcohol dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/35138|m.10741 | UnnamedSample_HQ_transcript/35138 | Coverage 0.446 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF00107 | Zinc-binding dehydrogenase | 188 | 317 | 1.3E-13 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/35138|m.10741 | UnnamedSample_HQ_transcript/35138 | Coverage 0.446 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF08240 | Alcohol dehydrogenase GroES-like domain | 65 | 126 | 1.8E-13 | T | 22-09-2020 | IPR013154 | Alcohol dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/76596|m.19136 | UnnamedSample_HQ_transcript/76596 | Coverage 0.732 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF00107 | Zinc-binding dehydrogenase | 188 | 317 | 1.3E-13 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/76596|m.19136 | UnnamedSample_HQ_transcript/76596 | Coverage 0.732 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF08240 | Alcohol dehydrogenase GroES-like domain | 65 | 126 | 1.8E-13 | T | 22-09-2020 | IPR013154 | Alcohol dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/77730|m.19334 | UnnamedSample_HQ_transcript/77730 | Coverage 0.721 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF00107 | Zinc-binding dehydrogenase | 188 | 317 | 1.3E-13 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/77730|m.19334 | UnnamedSample_HQ_transcript/77730 | Coverage 0.721 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF08240 | Alcohol dehydrogenase GroES-like domain | 65 | 126 | 1.8E-13 | T | 22-09-2020 | IPR013154 | Alcohol dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/85798|m.20621 | UnnamedSample_HQ_transcript/85798 | Coverage 0.783 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF00107 | Zinc-binding dehydrogenase | 188 | 317 | 1.3E-13 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/85798|m.20621 | UnnamedSample_HQ_transcript/85798 | Coverage 0.783 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF08240 | Alcohol dehydrogenase GroES-like domain | 65 | 126 | 1.8E-13 | T | 22-09-2020 | IPR013154 | Alcohol dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/34092|m.10491 | UnnamedSample_HQ_transcript/34092 | Coverage 0.442 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF00107 | Zinc-binding dehydrogenase | 188 | 317 | 1.3E-13 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/34092|m.10491 | UnnamedSample_HQ_transcript/34092 | Coverage 0.442 too low. | 18e88d38b87a53f02740607cfecbddc0 | 433 | Pfam | PF08240 | Alcohol dehydrogenase GroES-like domain | 65 | 126 | 1.8E-13 | T | 22-09-2020 | IPR013154 | Alcohol dehydrogenase, N-terminal |
| UnnamedSample_HQ_transcript/3147|m.1502 | UnnamedSample_HQ_transcript/3147 | Coverage 0.131 too low. | fbfe18d9638b632cc66fab2308003dbe | 869 | Pfam | PF19057 | PH domain | 523 | 656 | 2.1E-38 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/3147|m.1502 | UnnamedSample_HQ_transcript/3147 | Coverage 0.131 too low. | fbfe18d9638b632cc66fab2308003dbe | 869 | Pfam | PF00621 | RhoGEF domain | 318 | 498 | 6.3E-36 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/40691|m.12007 | UnnamedSample_HQ_transcript/40691 | Identity 0.950 too low. | f94dbf15a03d4c90d4ab864eac5f162f | 645 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 390 | 459 | 5.3E-25 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/40691|m.12007 | UnnamedSample_HQ_transcript/40691 | Identity 0.950 too low. | f94dbf15a03d4c90d4ab864eac5f162f | 645 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 292 | 357 | 2.5E-11 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/40691|m.12007 | UnnamedSample_HQ_transcript/40691 | Identity 0.950 too low. | f94dbf15a03d4c90d4ab864eac5f162f | 645 | Pfam | PF15519 | linker between RRM2 and RRM3 domains in RBM39 protein | 478 | 554 | 3.5E-22 | T | 22-09-2020 | IPR029123 | Splicing factor RBM39, linker |
| UnnamedSample_HQ_transcript/42404|m.12351 | UnnamedSample_HQ_transcript/42404 | Identity 0.938 too low. | 94323f5ba69f7521c58d38478a61495a | 540 | Pfam | PF00665 | Integrase core domain | 92 | 188 | 1.3E-8 | T | 22-09-2020 | IPR001584 | Integrase, catalytic core |
| UnnamedSample_HQ_transcript/20958|m.7136 | UnnamedSample_HQ_transcript/20958 | Coverage 0.364 too low. | e56164ecede996290bfbdf2915d75c46 | 862 | Pfam | PF03451 | HELP motif | 229 | 301 | 1.2E-31 | T | 22-09-2020 | IPR005108 | HELP |
| UnnamedSample_HQ_transcript/20958|m.7136 | UnnamedSample_HQ_transcript/20958 | Coverage 0.364 too low. | e56164ecede996290bfbdf2915d75c46 | 862 | Pfam | PF00400 | WD domain, G-beta repeat | 824 | 860 | 0.025 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/20958|m.7136 | UnnamedSample_HQ_transcript/20958 | Coverage 0.364 too low. | e56164ecede996290bfbdf2915d75c46 | 862 | Pfam | PF00400 | WD domain, G-beta repeat | 665 | 700 | 0.054 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/20958|m.7136 | UnnamedSample_HQ_transcript/20958 | Coverage 0.364 too low. | e56164ecede996290bfbdf2915d75c46 | 862 | Pfam | PF00400 | WD domain, G-beta repeat | 305 | 350 | 2.4E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/20958|m.7136 | UnnamedSample_HQ_transcript/20958 | Coverage 0.364 too low. | e56164ecede996290bfbdf2915d75c46 | 862 | Pfam | PF00400 | WD domain, G-beta repeat | 712 | 747 | 0.004 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/99902|m.22619 | UnnamedSample_HQ_transcript/99902 | Unmapped. | 5a28b7d21d6937278f6fa6f61461ed08 | 240 | Pfam | PF08762 | CRPV capsid protein like | 59 | 210 | 8.9E-11 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/102593|m.22938 | UnnamedSample_HQ_transcript/102593 | Coverage 0.446 too low. | 223dfa2b974c4e6a8eb37bcd2cddf278 | 147 | Pfam | PF00096 | Zinc finger, C2H2 type | 122 | 144 | 1.5E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/49583|m.13930 | UnnamedSample_HQ_transcript/49583 | Coverage 0.239 too low. | 2e03ff73b5283551ba60d32bd95f56a6 | 659 | Pfam | PF03160 | Calx-beta domain | 179 | 271 | 8.5E-22 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/49583|m.13930 | UnnamedSample_HQ_transcript/49583 | Coverage 0.239 too low. | 2e03ff73b5283551ba60d32bd95f56a6 | 659 | Pfam | PF03160 | Calx-beta domain | 289 | 386 | 2.2E-21 | T | 22-09-2020 | IPR003644 | Na-Ca exchanger/integrin-beta4 |
| UnnamedSample_HQ_transcript/49583|m.13930 | UnnamedSample_HQ_transcript/49583 | Coverage 0.239 too low. | 2e03ff73b5283551ba60d32bd95f56a6 | 659 | Pfam | PF01699 | Sodium/calcium exchanger protein | 484 | 648 | 1.7E-17 | T | 22-09-2020 | IPR004837 | Sodium/calcium exchanger membrane region |
| UnnamedSample_HQ_transcript/120568|m.24885 | UnnamedSample_HQ_transcript/120568 | Unmapped. | 7e8e4b5b601d7d3e2977e6e63ddbf68f | 196 | Pfam | PF01025 | GrpE | 34 | 196 | 1.0E-45 | T | 22-09-2020 | IPR000740 | GrpE nucleotide exchange factor |
| UnnamedSample_HQ_transcript/81449|m.19949 | UnnamedSample_HQ_transcript/81449 | Coverage 0.696 too low. | 4c6260eadebeb2cbe64fcbe2d5cb9052 | 292 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 54 | 244 | 4.4E-43 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/4038|m.1820 | UnnamedSample_HQ_transcript/4038 | Coverage 0.879 too low. | a534969da6e629c14bc95283d41aea76 | 1277 | Pfam | PF01390 | SEA domain | 1003 | 1100 | 1.2E-15 | T | 22-09-2020 | IPR000082 | SEA domain |
| UnnamedSample_HQ_transcript/22019|m.7430 | UnnamedSample_HQ_transcript/22019 | Identity 0.946 too low. | 7a971c0fde84071ab776d59f81a94b04 | 507 | Pfam | PF08416 | Phosphotyrosine-binding domain | 26 | 147 | 7.9E-17 | T | 22-09-2020 | IPR013625 | Tensin/EPS8 phosphotyrosine-binding domain |
| UnnamedSample_HQ_transcript/24411|m.8050 | UnnamedSample_HQ_transcript/24411 | Identity 0.937 too low. | 241ca5f71fa121a001797d1d09783907 | 332 | Pfam | PF00022 | Actin | 7 | 332 | 1.9E-132 | T | 22-09-2020 | IPR004000 | Actin family |
| UnnamedSample_HQ_transcript/54821|m.15010 | UnnamedSample_HQ_transcript/54821 | Identity 0.592 too low. | 23d9a95f3c565443176cdeeb4b57481a | 488 | Pfam | PF00448 | SRP54-type protein, GTPase domain | 270 | 487 | 8.1E-50 | T | 22-09-2020 | IPR000897 | Signal recognition particle, SRP54 subunit, GTPase domain |
| UnnamedSample_HQ_transcript/54821|m.15010 | UnnamedSample_HQ_transcript/54821 | Identity 0.592 too low. | 23d9a95f3c565443176cdeeb4b57481a | 488 | Pfam | PF02881 | SRP54-type protein, helical bundle domain | 169 | 239 | 6.3E-10 | T | 22-09-2020 | IPR013822 | Signal recognition particle SRP54, helical bundle |
| UnnamedSample_HQ_transcript/54821|m.15010 | UnnamedSample_HQ_transcript/54821 | Identity 0.592 too low. | 23d9a95f3c565443176cdeeb4b57481a | 488 | Pfam | PF04086 | Signal recognition particle, alpha subunit, N-terminal | 2 | 147 | 7.4E-11 | T | 22-09-2020 | IPR007222 | Signal recognition particle receptor, alpha subunit, N-terminal |
| UnnamedSample_HQ_transcript/121607|m.24965 | UnnamedSample_HQ_transcript/121607 | Coverage 0.988 too low. | d794bf75e07ac90b873293a9473a77e0 | 159 | Pfam | PF01938 | TRAM domain | 56 | 115 | 5.2E-7 | T | 22-09-2020 | IPR002792 | TRAM domain |
| UnnamedSample_HQ_transcript/6359|m.2657 | UnnamedSample_HQ_transcript/6359 | Coverage 0.110 too low. | 53109418d2f4e542c47177e952bda6d8 | 466 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 239 | 307 | 8.0E-15 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/6359|m.2657 | UnnamedSample_HQ_transcript/6359 | Coverage 0.110 too low. | 53109418d2f4e542c47177e952bda6d8 | 466 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 151 | 219 | 7.4E-16 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/41084|m.12080 | UnnamedSample_HQ_transcript/41084 | Coverage 0.121 too low. | 76bf7643a9768f2dc9dc9af745d0049e | 377 | Pfam | PF10160 | Predicted membrane protein | 39 | 292 | 2.4E-71 | T | 22-09-2020 | IPR018781 | Transmembrane protein TPRA1/CAND2/CAND8 |
| UnnamedSample_HQ_transcript/59970|m.16051 | UnnamedSample_HQ_transcript/59970 | Coverage 0.149 too low. | 76bf7643a9768f2dc9dc9af745d0049e | 377 | Pfam | PF10160 | Predicted membrane protein | 39 | 292 | 2.4E-71 | T | 22-09-2020 | IPR018781 | Transmembrane protein TPRA1/CAND2/CAND8 |
| UnnamedSample_HQ_transcript/73321|m.18527 | UnnamedSample_HQ_transcript/73321 | Coverage 0.173 too low. | 76bf7643a9768f2dc9dc9af745d0049e | 377 | Pfam | PF10160 | Predicted membrane protein | 39 | 292 | 2.4E-71 | T | 22-09-2020 | IPR018781 | Transmembrane protein TPRA1/CAND2/CAND8 |
| UnnamedSample_HQ_transcript/45111|m.12933 | UnnamedSample_HQ_transcript/45111 | Coverage 0.126 too low. | 76bf7643a9768f2dc9dc9af745d0049e | 377 | Pfam | PF10160 | Predicted membrane protein | 39 | 292 | 2.4E-71 | T | 22-09-2020 | IPR018781 | Transmembrane protein TPRA1/CAND2/CAND8 |
| UnnamedSample_HQ_transcript/48289|m.13647 | UnnamedSample_HQ_transcript/48289 | Coverage 0.130 too low. | 76bf7643a9768f2dc9dc9af745d0049e | 377 | Pfam | PF10160 | Predicted membrane protein | 39 | 292 | 2.4E-71 | T | 22-09-2020 | IPR018781 | Transmembrane protein TPRA1/CAND2/CAND8 |
| UnnamedSample_HQ_transcript/51476|m.14347 | UnnamedSample_HQ_transcript/51476 | Coverage 0.986 too low. | 682c5d045684f6f6f756332c5c34ce47 | 689 | Pfam | PF00014 | Kunitz/Bovine pancreatic trypsin inhibitor domain | 362 | 413 | 1.3E-17 | T | 22-09-2020 | IPR002223 | Pancreatic trypsin inhibitor Kunitz domain |
| UnnamedSample_HQ_transcript/51476|m.14347 | UnnamedSample_HQ_transcript/51476 | Coverage 0.986 too low. | 682c5d045684f6f6f756332c5c34ce47 | 689 | Pfam | PF00014 | Kunitz/Bovine pancreatic trypsin inhibitor domain | 421 | 472 | 3.2E-16 | T | 22-09-2020 | IPR002223 | Pancreatic trypsin inhibitor Kunitz domain |
| UnnamedSample_HQ_transcript/51476|m.14347 | UnnamedSample_HQ_transcript/51476 | Coverage 0.986 too low. | 682c5d045684f6f6f756332c5c34ce47 | 689 | Pfam | PF13927 | Immunoglobulin domain | 482 | 557 | 2.0E-16 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/51476|m.14347 | UnnamedSample_HQ_transcript/51476 | Coverage 0.986 too low. | 682c5d045684f6f6f756332c5c34ce47 | 689 | Pfam | PF13927 | Immunoglobulin domain | 608 | 683 | 4.8E-13 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/41181|m.12092 | UnnamedSample_HQ_transcript/41181 | Coverage 0.623 too low. | e4de03c9fb4370f60ce2f3031b3f73f6 | 551 | Pfam | PF00485 | Phosphoribulokinase / Uridine kinase family | 113 | 301 | 6.7E-56 | T | 22-09-2020 | IPR006083 | Phosphoribulokinase/uridine kinase |
| UnnamedSample_HQ_transcript/41181|m.12092 | UnnamedSample_HQ_transcript/41181 | Coverage 0.623 too low. | e4de03c9fb4370f60ce2f3031b3f73f6 | 551 | Pfam | PF14681 | Uracil phosphoribosyltransferase | 343 | 546 | 4.1E-73 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/42376|m.12343 | UnnamedSample_HQ_transcript/42376 | Coverage 0.597 too low. | e4de03c9fb4370f60ce2f3031b3f73f6 | 551 | Pfam | PF00485 | Phosphoribulokinase / Uridine kinase family | 113 | 301 | 6.7E-56 | T | 22-09-2020 | IPR006083 | Phosphoribulokinase/uridine kinase |
| UnnamedSample_HQ_transcript/42376|m.12343 | UnnamedSample_HQ_transcript/42376 | Coverage 0.597 too low. | e4de03c9fb4370f60ce2f3031b3f73f6 | 551 | Pfam | PF14681 | Uracil phosphoribosyltransferase | 343 | 546 | 4.1E-73 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/36140|m.10965 | UnnamedSample_HQ_transcript/36140 | Coverage 0.597 too low. | e4de03c9fb4370f60ce2f3031b3f73f6 | 551 | Pfam | PF00485 | Phosphoribulokinase / Uridine kinase family | 113 | 301 | 6.7E-56 | T | 22-09-2020 | IPR006083 | Phosphoribulokinase/uridine kinase |
| UnnamedSample_HQ_transcript/36140|m.10965 | UnnamedSample_HQ_transcript/36140 | Coverage 0.597 too low. | e4de03c9fb4370f60ce2f3031b3f73f6 | 551 | Pfam | PF14681 | Uracil phosphoribosyltransferase | 343 | 546 | 4.1E-73 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/40812|m.12029 | UnnamedSample_HQ_transcript/40812 | Coverage 0.626 too low. | e4de03c9fb4370f60ce2f3031b3f73f6 | 551 | Pfam | PF00485 | Phosphoribulokinase / Uridine kinase family | 113 | 301 | 6.7E-56 | T | 22-09-2020 | IPR006083 | Phosphoribulokinase/uridine kinase |
| UnnamedSample_HQ_transcript/40812|m.12029 | UnnamedSample_HQ_transcript/40812 | Coverage 0.626 too low. | e4de03c9fb4370f60ce2f3031b3f73f6 | 551 | Pfam | PF14681 | Uracil phosphoribosyltransferase | 343 | 546 | 4.1E-73 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/108024|m.23580 | UnnamedSample_HQ_transcript/108024 | Coverage 0.628 too low. | ac16180a24ea1080eae3f1a159d8e69c | 209 | Pfam | PF13895 | Immunoglobulin domain | 25 | 109 | 1.8E-6 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/108024|m.23580 | UnnamedSample_HQ_transcript/108024 | Coverage 0.628 too low. | ac16180a24ea1080eae3f1a159d8e69c | 209 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 139 | 182 | 2.4E-4 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/66453|m.17303 | UnnamedSample_HQ_transcript/66453 | Coverage 0.525 too low. | 016cdc6e7a9379175b0259346b39a033 | 572 | Pfam | PF00012 | Hsp70 protein | 5 | 570 | 5.7E-223 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/19401|m.6701 | UnnamedSample_HQ_transcript/19401 | Coverage 0.818 too low. | 39950b4386068736c2249d60c36018a7 | 609 | Pfam | PF04516 | CP2 transcription factor | 176 | 392 | 1.1E-69 | T | 22-09-2020 | IPR007604 | CP2 transcription factor |
| UnnamedSample_HQ_transcript/19401|m.6701 | UnnamedSample_HQ_transcript/19401 | Coverage 0.818 too low. | 39950b4386068736c2249d60c36018a7 | 609 | Pfam | PF18016 | SAM domain (Sterile alpha motif) | 468 | 528 | 5.5E-16 | T | 22-09-2020 | IPR041418 | SAM domain |
| UnnamedSample_HQ_transcript/72465|m.18377 | UnnamedSample_HQ_transcript/72465 | Coverage 0.820 too low. | e2bcdff1100d767667efde1405d7d5e4 | 548 | Pfam | PF00916 | Sulfate permease family | 1 | 368 | 1.8E-79 | T | 22-09-2020 | IPR011547 | SLC26A/SulP transporter domain |
| UnnamedSample_HQ_transcript/72465|m.18377 | UnnamedSample_HQ_transcript/72465 | Coverage 0.820 too low. | e2bcdff1100d767667efde1405d7d5e4 | 548 | Pfam | PF01740 | STAS domain | 409 | 498 | 4.5E-6 | T | 22-09-2020 | IPR002645 | STAS domain |
| UnnamedSample_HQ_transcript/40443|m.11953 | UnnamedSample_HQ_transcript/40443 | Coverage 0.885 too low. | 5bd3f168e0b0b54fec133af7b68dedfc | 424 | Pfam | PF00372 | Hemocyanin, copper containing domain | 153 | 394 | 2.7E-59 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/40443|m.11953 | UnnamedSample_HQ_transcript/40443 | Coverage 0.885 too low. | 5bd3f168e0b0b54fec133af7b68dedfc | 424 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 64 | 143 | 8.0E-17 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/23386|m.7784 | UnnamedSample_HQ_transcript/23386 | Coverage 0.949 too low. | 466cd375679acfe6e1db57f9e9b1b64b | 443 | Pfam | PF00002 | 7 transmembrane receptor (Secretin family) | 117 | 394 | 4.7E-54 | T | 22-09-2020 | IPR000832 | GPCR, family 2, secretin-like |
| UnnamedSample_HQ_transcript/23386|m.7784 | UnnamedSample_HQ_transcript/23386 | Coverage 0.949 too low. | 466cd375679acfe6e1db57f9e9b1b64b | 443 | Pfam | PF02793 | Hormone receptor domain | 42 | 106 | 9.4E-13 | T | 22-09-2020 | IPR001879 | GPCR, family 2, extracellular hormone receptor domain |
| UnnamedSample_HQ_transcript/25542|m.8354 | UnnamedSample_HQ_transcript/25542 | Coverage 0.948 too low. | 466cd375679acfe6e1db57f9e9b1b64b | 443 | Pfam | PF00002 | 7 transmembrane receptor (Secretin family) | 117 | 394 | 4.7E-54 | T | 22-09-2020 | IPR000832 | GPCR, family 2, secretin-like |
| UnnamedSample_HQ_transcript/25542|m.8354 | UnnamedSample_HQ_transcript/25542 | Coverage 0.948 too low. | 466cd375679acfe6e1db57f9e9b1b64b | 443 | Pfam | PF02793 | Hormone receptor domain | 42 | 106 | 9.4E-13 | T | 22-09-2020 | IPR001879 | GPCR, family 2, extracellular hormone receptor domain |
| UnnamedSample_HQ_transcript/63150|m.16667 | UnnamedSample_HQ_transcript/63150 | Coverage 0.117 too low. | 9cd3c1470a4540e8a8101a769f4b35d0 | 622 | Pfam | PF05029 | Timeless PAB domain | 405 | 485 | 2.9E-21 | T | 22-09-2020 | IPR007725 | Timeless, C-terminal |
| UnnamedSample_HQ_transcript/110153|m.23856 | UnnamedSample_HQ_transcript/110153 | Identity 0.911 too low. | 41585b6ab636a4b29dbddeabbd2a0c07 | 211 | Pfam | PF00071 | Ras family | 6 | 187 | 1.0E-10 | T | 22-09-2020 | IPR001806 | Small GTPase |
| UnnamedSample_HQ_transcript/407|m.317 | UnnamedSample_HQ_transcript/407 | Coverage 0.049 too low. | ea80ec95f142c611b8eae970e3ef025d | 1876 | Pfam | PF00096 | Zinc finger, C2H2 type | 1356 | 1378 | 3.9E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/407|m.317 | UnnamedSample_HQ_transcript/407 | Coverage 0.049 too low. | ea80ec95f142c611b8eae970e3ef025d | 1876 | Pfam | PF00096 | Zinc finger, C2H2 type | 1384 | 1408 | 0.0046 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/407|m.317 | UnnamedSample_HQ_transcript/407 | Coverage 0.049 too low. | ea80ec95f142c611b8eae970e3ef025d | 1876 | Pfam | PF00096 | Zinc finger, C2H2 type | 1710 | 1731 | 0.0036 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/526|m.388 | UnnamedSample_HQ_transcript/526 | Coverage 0.050 too low. | ea80ec95f142c611b8eae970e3ef025d | 1876 | Pfam | PF00096 | Zinc finger, C2H2 type | 1356 | 1378 | 3.9E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/526|m.388 | UnnamedSample_HQ_transcript/526 | Coverage 0.050 too low. | ea80ec95f142c611b8eae970e3ef025d | 1876 | Pfam | PF00096 | Zinc finger, C2H2 type | 1384 | 1408 | 0.0046 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/526|m.388 | UnnamedSample_HQ_transcript/526 | Coverage 0.050 too low. | ea80ec95f142c611b8eae970e3ef025d | 1876 | Pfam | PF00096 | Zinc finger, C2H2 type | 1710 | 1731 | 0.0036 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/32178|m.9995 | UnnamedSample_HQ_transcript/32178 | Coverage 0.561 too low. | bc1a1a1b017b6d96e498b44221b5e679 | 462 | Pfam | PF01153 | Glypican | 27 | 460 | 5.0E-81 | T | 22-09-2020 | IPR001863 | Glypican |
| UnnamedSample_HQ_transcript/58073|m.15667 | UnnamedSample_HQ_transcript/58073 | Coverage 0.739 too low. | bc1a1a1b017b6d96e498b44221b5e679 | 462 | Pfam | PF01153 | Glypican | 27 | 460 | 5.0E-81 | T | 22-09-2020 | IPR001863 | Glypican |
| UnnamedSample_HQ_transcript/33650|m.10375 | UnnamedSample_HQ_transcript/33650 | Coverage 0.961 too low. | 9acff7fa387241c5b351a90591993a85 | 739 | Pfam | PF13949 | ALIX V-shaped domain binding to HIV | 416 | 707 | 2.0E-81 | T | 22-09-2020 | IPR025304 | ALIX V-shaped domain |
| UnnamedSample_HQ_transcript/33650|m.10375 | UnnamedSample_HQ_transcript/33650 | Coverage 0.961 too low. | 9acff7fa387241c5b351a90591993a85 | 739 | Pfam | PF03097 | BRO1-like domain | 8 | 380 | 1.2E-110 | T | 22-09-2020 | IPR004328 | BRO1 domain |
| UnnamedSample_HQ_transcript/78096|m.19386 | UnnamedSample_HQ_transcript/78096 | Coverage 0.829 too low. | 9efe2eff91244950b5fc444020b5f6b5 | 381 | Pfam | PF04666 | N-Acetylglucosaminyltransferase-IV (GnT-IV) conserved region | 1 | 220 | 1.4E-94 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/97982|m.22361 | UnnamedSample_HQ_transcript/97982 | Coverage 0.597 too low. | 3de1b65c02c4d4ffcfc0705e136b9b38 | 357 | Pfam | PF00876 | Innexin | 20 | 350 | 3.2E-95 | T | 22-09-2020 | IPR000990 | Innexin |
| UnnamedSample_HQ_transcript/117731|m.24658 | UnnamedSample_HQ_transcript/117731 | Coverage 0.984 too low. | 1b7978c6a5b5df9867b2d8019e75c08c | 187 | Pfam | PF00572 | Ribosomal protein L13 | 15 | 118 | 9.4E-24 | T | 22-09-2020 | IPR005822 | Ribosomal protein L13 |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
